The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy by Cordani, Marco et al.
                                   [Translational Medicine Reports 2017; 1:]                                                     [page 11]
The antioxidant mitochondrialprotein UCP2 promotes cancerdevelopment connecting theWarburg effect and autophagy
Marco Cordani, Giovanna Butera,
Raffaella Pacchiana, Massimo Donadelli
Department of Neuroscience,
Biomedicine and Movement,
Biochemistry Section, University 
of Verona, Verona, Italy
Uncoupling proteins (UCPs) are
mitochondrial anion transporter proteins
localized into the mitochondrial inner
membrane.1 Currently, five UCP family
members have been identified in mammals.
Among them, UCP2 is widely distributed
throughout the organism, suggesting
different and wide functions for this
mitochondrial uncoupling protein.2
Basically, the antioxidant role of UCP2 is
due to its capability to decrease the
mitochondrial potential and to dissipate the
proton gradient. This prevents the proton-
motive force from becoming excessive, thus
decreasing reactive oxygen species (ROS),
especially superoxide ions, produced by
leakage of electrons from the mitochondrial
transport chain.3 UCP2 is a redox sensitive
protein functioning as a mitochondrial
redox sensor. As a result of oxidation,
UCP2 is activated becoming an important
component of antioxidant feedback mecha-
nisms commonly implicated in cyto-protec-
tive events controlling the production of
mitochondrial ROS and regulating redox-
sensitive cytosolic signaling pathways.
UCP2 participates to the development
of several diseases, including many types of
cancers in which it is generally over-
expressed.4 In tumors, some studies have
well established the key role that UCP2 has
in both tumorigenesis and chemore -
sistance.5 Indeed, during the first stages of
tumorigenesis UCP2 is down-regulated
likely to allow ROS increase and genomic
instability, while it is triggered and over-
expressed in the later stages of cancer
development, causing resistance of
malignant cells to therapies and tumor
aggressiveness mainly through anti-
apoptotic mechanisms induced by the
attenuation of ROS production. 
The antioxidant function of UCP2 can
be considered a crossroad between the
Warburg effect and autophagy regulation in
cancer cells (Figure 1). Xu et al. stated that
mitochondrial uncoupling mediated by
UCPs leads the shift of cancer cell
metabolism from mitochondrial oxidative
phosphorylation (OXPHOS) to aerobic
glycolysis.6 The authors associate the
production of mitochondrial ROS
determined by a deficiency of MnSOD
enzyme to the stimulation of mitochondrial
uncoupling and of aerobic glycolysis. In
this way, the Warburg effect can be
considered as a metabolic adaptation of
cancer cells bearing antioxidant-deficient
mitochondria. It’s worth noting that data
presented by Xu et al. support the previous
knowledge concerning the UCP2
involvement in the maintenance of the
Warburg effect in cancer cells, as
demonstrated by the high production of
lactate after overexpression of uncoupling
proteins.7 In addition to the antioxidant
properties of UCPs by allowing the flux of
protons from the intermembrane space to
the mitochondrial matrix, the channel
formed by these proteins can also promote
the mitochondrial efflux towards the
cytosol of pyruvate and of Krebs cycle
intermediates, thus limiting the
mitochondrial oxidation of glucose and
supporting the Warburg effect.8 We have
recently found that the antioxidant UCP2
induces the expression of GLUT1 and
pyruvate kinase isoform M2 (PKM2)
sustaining the glycolytic phenotype of
pancreatic adenocarcinoma cells and
sensitizing cancer cells to the glycolysis
inhibitor 2-deoxy-D-glucose. Furthermore,
we observed that UCP2 reduces
mitochondrial oxygen consumption and
OXPHOS functionality acting as a crucial
mediator in cancer cellular bioenergetic
shift from OXPHOS to the glycolytic
pathway.9
Together with the regulation of the
cellular metabolism, another highly debated
topic in cancer research is the regulation of
autophagy, a process determining the
lysosomal degradation of proteins and
cytoplasmic organelles. This event is
largely involved in the control of tumor
progression and many efforts are directed in
order to explore the regulation of autophagy
as a possible therapeutic opportunity. Our
recent studies demonstrated that
mitochondrial uncoupling mediated by
UCP2 inhibits autophagic cell death making
pancreatic adenocarcinoma cells
particularly resistant to the anticancer drug
gemcitabine.10,11 We have functionally
associated this phenomenon with the
UCP2-mediated cytosolic stabilization of
the glycolytic enzyme glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).11
Indeed, ROS produced by inhibition of
UCP2 are able to stimulate the oxidation of
this glycolytic enzyme determining its
conformational changes, which favor its
translocation into the nucleus where it can
subsequently activate the expression of
GAPDH-regulated genes, as the crucial
autophagic gene Atg12. Therefore, the
observation that UCPs can prevent the
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Figure 1. Schematic representation of the involvement of UCP2 in both the metabolic
shift from mitochondrial oxidative phosphorylation to aerobic glycolysis and autophagy
blockage in order to sustain cancer development.
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formation of autophagic vesicles and the
activation of autophagic genes concurrently
stabilizing the glycolytic enzyme GAPDH
in the cytosol, where glycolysis takes place,
makes mitochondrial uncoupling a
functional crossroad between the Warburg
effect and the inhibition of autophagy.
Altogether these observations provide a
rational explanation for the oncogenic roles
of UCP2, whose overexpression in cancer
cells can be considered a valuable
therapeutic opportunity for the
identification of novel target therapies.
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